fig1

Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma

Figure 1. Timeline of FDA approved systemic therapies for advanced HCC

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/